Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA systemDirk Vordermark, Matthias Bache, Harun M. Said et al.|BMC Cancer|2006Cited by 59
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levelsMatthias Bache, Dirk Vordermark, Helge Täubert et al.|International Journal of Radiation Oncology*Biology*Physics|2006Cited by 58
Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinomaThomas Greither, Alexander W. Eckert, Freya Vorwerk et al.|Oncology Reports|2017Cited by 45
Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck CancerMatthias Kappler, Matthias Bache, Helge Täubert et al.|Strahlentherapie und Onkologie|2008Cited by 41
Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck CancerMatthias Kappler, Matthias Bache, Helge Täubert et al.|Strahlentherapie und Onkologie|2008Cited by 28